ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 966 filers reported holding ASTRAZENECA PLC in Q1 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $474,040 | -5.4% | 7,000 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $500,990 | +3.1% | 7,000 | 0.0% | 0.02% | -4.2% |
| Q1 2023 | $485,870 | +2.4% | 7,000 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $474,600 | +23.6% | 7,000 | 0.0% | 0.02% | +14.3% |
| Q3 2022 | $384,000 | -16.9% | 7,000 | 0.0% | 0.02% | -12.5% |
| Q2 2022 | $462,000 | -2.5% | 7,000 | -2.2% | 0.02% | +20.0% |
| Q1 2022 | $474,000 | +12.1% | 7,158 | -1.5% | 0.02% | +25.0% |
| Q4 2021 | $423,000 | -1.6% | 7,268 | +1.5% | 0.02% | -11.1% |
| Q3 2021 | $430,000 | -0.9% | 7,158 | -1.1% | 0.02% | 0.0% |
| Q2 2021 | $434,000 | +16.4% | 7,238 | -3.4% | 0.02% | +12.5% |
| Q1 2021 | $373,000 | -11.8% | 7,494 | -11.5% | 0.02% | -20.0% |
| Q4 2020 | $423,000 | -31.7% | 8,469 | -25.1% | 0.02% | -37.5% |
| Q3 2020 | $619,000 | +8.8% | 11,304 | +5.2% | 0.03% | 0.0% |
| Q2 2020 | $569,000 | +73.5% | 10,749 | +46.3% | 0.03% | +39.1% |
| Q1 2020 | $328,000 | -10.4% | 7,345 | 0.0% | 0.02% | +15.0% |
| Q4 2019 | $366,000 | +17.3% | 7,345 | +4.9% | 0.02% | -35.5% |
| Q3 2019 | $312,000 | +8.0% | 7,000 | 0.0% | 0.03% | 0.0% |
| Q2 2019 | $289,000 | -57.9% | 7,000 | -58.8% | 0.03% | -57.5% |
| Q1 2019 | $687,000 | +3.5% | 17,000 | -2.8% | 0.07% | 0.0% |
| Q4 2018 | $664,000 | -4.3% | 17,490 | -0.2% | 0.07% | +9.0% |
| Q3 2018 | $694,000 | -19.2% | 17,531 | -28.4% | 0.07% | -23.0% |
| Q2 2018 | $859,000 | -0.7% | 24,480 | -1.1% | 0.09% | -2.2% |
| Q1 2018 | $865,000 | +16.7% | 24,748 | +15.9% | 0.09% | +14.1% |
| Q4 2017 | $741,000 | -22.6% | 21,348 | -24.5% | 0.08% | -4.9% |
| Q3 2017 | $957,000 | +253.1% | 28,262 | +255.8% | 0.08% | +70.8% |
| Q2 2017 | $271,000 | +14.8% | 7,944 | +4.9% | 0.05% | +6.7% |
| Q1 2017 | $236,000 | +15.1% | 7,571 | +0.7% | 0.04% | +12.5% |
| Q4 2016 | $205,000 | -16.3% | 7,517 | +0.7% | 0.04% | -25.9% |
| Q3 2016 | $245,000 | +14.0% | 7,462 | +4.6% | 0.05% | +14.9% |
| Q2 2016 | $215,000 | +7.0% | 7,136 | 0.0% | 0.05% | +9.3% |
| Q1 2016 | $201,000 | -14.5% | 7,136 | +3.3% | 0.04% | -2.3% |
| Q4 2015 | $235,000 | +6.8% | 6,911 | 0.0% | 0.04% | +7.3% |
| Q3 2015 | $220,000 | – | 6,911 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |